These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

99 related items for PubMed ID: 2172742

  • 1. Kadsurenone and other related lignans as antagonists of platelet-activating factor receptor.
    Shen TY, Hussaini IM.
    Methods Enzymol; 1990; 187():446-54. PubMed ID: 2172742
    [No Abstract] [Full Text] [Related]

  • 2. Structure-activity relationships of kadsurenone analogues.
    Ponpipom MM, Bugianesi RL, Brooker DR, Yue BZ, Hwang SB, Shen TY.
    J Med Chem; 1987 Jan; 30(1):136-42. PubMed ID: 3027330
    [Abstract] [Full Text] [Related]

  • 3. The isolation and characterization of kadsurenone from haifenteng (Piper futokadsura) as an orally active specific receptor antagonist of platelet-activating factor.
    Shen TY, Hwang SB, Chang MN, Doebber TW, Lam MH, Wu MS, Wang X.
    Int J Tissue React; 1985 Jan; 7(5):339-43. PubMed ID: 2997065
    [Abstract] [Full Text] [Related]

  • 4. Species difference in the specific receptors of platelet activating factor.
    Hwang SB, Lam MH.
    Biochem Pharmacol; 1986 Dec 15; 35(24):4511-8. PubMed ID: 3024653
    [Abstract] [Full Text] [Related]

  • 5. [Antagonists of platelet activating factor].
    Tokumura A, Tsukatani H.
    Seikagaku; 1985 Dec 15; 57(12):1618-23. PubMed ID: 3009656
    [No Abstract] [Full Text] [Related]

  • 6. Characterization of a platelet-activating factor receptor antagonist isolated from haifenteng (Piper futokadsura): specific inhibition of in vitro and in vivo platelet-activating factor-induced effects.
    Shen TY, Hwang SB, Chang MN, Doebber TW, Lam MH, Wu MS, Wang X, Han GQ, Li RZ.
    Proc Natl Acad Sci U S A; 1985 Feb 15; 82(3):672-6. PubMed ID: 2983307
    [Abstract] [Full Text] [Related]

  • 7. Specific binding of [3H]dihydrokadsurenone to rabbit platelet membranes and its inhibition by the receptor agonists and antagonists of platelet-activating factor.
    Hwang SB, Lam MH, Chang MN.
    J Biol Chem; 1986 Oct 15; 261(29):13720-6. PubMed ID: 3020044
    [Abstract] [Full Text] [Related]

  • 8. PAF-receptor. 1. 'Cache-oreilles' effect of selected high-potency platelet-activating factor (PAF) antagonists.
    Dive G, Godfroid JJ, Lamotte-Brasseur J, Batt JP, Heymans F, Dupont L, Braquet P.
    J Lipid Mediat; 1989 Oct 15; 1(4):201-15. PubMed ID: 2562434
    [Abstract] [Full Text] [Related]

  • 9. Cardiovascular alterations in the rabbit infused with platelet activating factor (PAF): effect of kadsurenone, a PAF-receptor antagonist.
    Montrucchio G, Alloatti G, Mariano F, Tetta C, Emanuelli G, Camussi G.
    Int J Tissue React; 1986 Oct 15; 8(6):497-504. PubMed ID: 3025124
    [Abstract] [Full Text] [Related]

  • 10. Platelet activating factor receptor blockade enhances recovery after multifocal brain ischemia.
    Kochanek PM, Dutka AJ, Kumaroo KK, Hallenbeck JM.
    Life Sci; 1987 Dec 14; 41(24):2639-44. PubMed ID: 2826947
    [Abstract] [Full Text] [Related]

  • 11. Chemical and biochemical characterization of lignan analogs as novel PAF receptor antagonists.
    Shen TY.
    Lipids; 1991 Dec 14; 26(12):1154-6. PubMed ID: 1668110
    [Abstract] [Full Text] [Related]

  • 12. Kadsurenone distinguishes between different platelet activating factor receptor subtypes on macrophages and polymorphonuclear leucocytes.
    Lambrecht G, Parnham MJ.
    Br J Pharmacol; 1986 Feb 14; 87(2):287-9. PubMed ID: 3006857
    [Abstract] [Full Text] [Related]

  • 13. trans-2,5-Bis-(3,4,5-trimethoxyphenyl)tetrahydrofuran. An orally active specific and competitive receptor antagonist of platelet activating factor.
    Hwang SB, Lam MH, Biftu T, Beattie TR, Shen TY.
    J Biol Chem; 1985 Dec 15; 260(29):15639-45. PubMed ID: 2999126
    [Abstract] [Full Text] [Related]

  • 14. Recent development of platelet-activating factor antagonists.
    Shen TY, Hussaini I, Hwang SB, Chang MN.
    Adv Prostaglandin Thromboxane Leukot Res; 1989 Dec 15; 19():359-62. PubMed ID: 2546389
    [No Abstract] [Full Text] [Related]

  • 15. Vasoconstrictor effects of platelet-activating factor in the hamster cheek pouch microcirculation: dose-related relations and pathways of action.
    Dillon PK, Ritter AB, Durán WN.
    Circ Res; 1988 Apr 15; 62(4):722-31. PubMed ID: 2832096
    [Abstract] [Full Text] [Related]

  • 16. Platelet activating factor (PAF) involvement in endotoxin-induced hypotension in rats. Studies with PAF-receptor antagonist kadsurenone.
    Doebber TW, Wu MS, Robbins JC, Choy BM, Chang MN, Shen TY.
    Biochem Biophys Res Commun; 1985 Mar 29; 127(3):799-808. PubMed ID: 2985058
    [Abstract] [Full Text] [Related]

  • 17. Ginkgolides and platelet-activating factor binding sites.
    Hosford DJ, Domingo MT, Chabrier PE, Braquet P.
    Methods Enzymol; 1990 Mar 29; 187():433-46. PubMed ID: 2172741
    [No Abstract] [Full Text] [Related]

  • 18. [Platelet activating factor and platelet activating factor antagonists. New methods in asthma therapy?].
    Uhl D.
    Med Monatsschr Pharm; 1989 Jun 29; 12(6):170-2. PubMed ID: 2544789
    [No Abstract] [Full Text] [Related]

  • 19. Differential effect of platelet-activating factor (PAF) receptor antagonists on peptide and PAF-stimulated prostaglandin release in unilateral ureteral obstruction.
    Weisman SM, Freund RM, Felsen D, Vaughan ED.
    Biochem Pharmacol; 1988 Aug 01; 37(15):2927-32. PubMed ID: 2840083
    [Abstract] [Full Text] [Related]

  • 20. Prehispanolone, a novel platelet activating factor receptor antagonist from Leonurus heterophyllus.
    Lee CM, Jiang LM, Shang HS, Hon PM, He Y, Wong HN.
    Br J Pharmacol; 1991 Jul 01; 103(3):1719-24. PubMed ID: 1657264
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.